Researchers recently found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage (EIPH) and long-term racing performance.
Unless horse racing first reaches industry consensus on medication reform, the NTRA does not expect Congress to move forward on federal legislation that would change current, state-level regulatory oversight.
In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight of drug compounders.
While some prominent trainers called for phasing out use of race-day furosemide in a press release Aug. 1, top horsemen’s groups throughout the country said this week they have not changed their stance in supporting use of the diuretic.
New study results show no difference in the racing career longevity between horses that experience some level of exercise-induced pulmonary hemorrhage (EIPH) and those that never experience the condition.
Presenters discussed how improved information collection is helping to improve racetrack surfaces throughout the United States.
Veterinarian Doug Byars, DVM, Dipl. ACVIM, age 70, died the evening of July 7 at his Georgetown, Kentucky home.
The Jockey Club has called on leading industry organizations to come together to conduct a study that would examine the timing of administration of Salix, the medication used to prevent or lessen the effects of exercise-induced pulmonary hemorrhage.
The Thoroughbred owners filed lawsuits seeking at least $250,000 in damages, alleging their horses were hospitalized after receiving a compounded drug to treat or prevent equine protozoal myeloencephalitis (EPM).
California Chrome will be allowed to wear a nasal strip when he tries to win the Triple Crown in the Belmont Stakes June 7 at Belmont Park, in Elmont, New York.
The FDA said initial testing on one lot of the compounded medication indicates the drug contained higher levels of pyrimethamine than the labeling states.
The KHRC has asked track veterinarians to participate in a study that will document how fast specific corticosteroids are eliminated from a horse’s system.
The U.S. Food and Drug Administration is investigating whether a compounded medication might have played a role in the deaths of two Thoroughbred horses and sickening several others, an agency representative said.
Trainer Bob Baffert believes Hoppertunity has a bruised foot but he wants to make 100% sure that is the only issue.
At least one regulator investigating violations alleged in a PETA video posted last month involving the stable of Thoroughbred racehorse trainer Steve Asmussen expects the inquiry to take at least several months.
Researchers concluded that a corticosteroid treatment’s desired therapeutic effects could be achieved at lower dosage levels than recommended by the manufacturer and commonly used on racehorses.
Stay on top of the most recent Horse Health news with
